NEPHROS INC·4

May 30, 4:35 PM ET

Amron Arthur H 4

4 · NEPHROS INC · Filed May 30, 2024

Insider Transaction Report

Form 4
Period: 2024-05-28
Transactions
  • Purchase

    Common Stock

    2024-05-28$2.22/sh+2,000$4,441100,463 total
  • Purchase

    Common Stock

    2024-05-30$2.24/sh+3,000$6,735103,463 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $2.14Exp: 2034-05-14Common Stock (7,323 underlying)
    7,323
Footnotes (3)
  • [F1]Represents a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.2138 to $2.2276, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  • [F2]Represents a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.237 to $2.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  • [F3]This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES